BBP
Virtus LifeSci Biotech Products ETF [BBP] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BBP Stock Summary
Top BBP Correlated Resources
BBP
Top 10 Correlated ETFs
BBP
Top 10 Correlated Stocks
BBP
In the News
BBP Financial details
Company Rating
-
Market Cap
19.41M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
2.7%
SMA50
-4.07%
SMA100
-1.06%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
45.0-63.25
52W High
+0.46%
52W Low
+40.64%
RSI
56.11
Rel Volume
3.28
Avg Volume
3.35K
Volume
10.99K
Perf Week
3.64%
Perf Month
2.89%
Perf Quarter
-0.66%
Perf Half Y
-1.02%
-
-
-
-
Beta
0.65
-
-
Volatility
0.76%, 1.34%
Prev Close
-0.85%
Price
63.29
Change
-0.53%
Company Profile
- Volume Average 3.35K
- Market Capitalization 19.41M
- Headquarters US
- IPO Date 2014-12-17
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
